Skip to main content
Caplight Logo









Weave Bio

Weave Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.weave.bio/

Last Round

Series A

Oct 16, 2025

Total Funding Raised

$36M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Weave Bio is a digital health company that provides an AI-native regulatory automation platform to streamline document preparation and lifecycle management for pharmaceutical and biotech companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Data Integration, Workflow Automation, RegTech, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical trial dataregulatory submissionRegTechregulatory technologyworkflow automationclinical data managementAI regulatory automationdrug development softwarebiotech AIlife sciences dataclinical research softwareenterprise SaaSregulatory compliancepharma techdata integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Weave Bio Comparables

Compare Weave Bio with similar companies based on industry and business-model similarity.

Weave Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hill Research
83%
Artos
83%
AlphaLife Sciences
81%

Weave Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 16, 2025
SeedMay 30, 2024
Pre SeedAug 7, 2022

Key People

Founding team and executive leadership

Ari Caroline

Co-founder & Chief Strategy Officer (CSO)

Founding Team

Brandon Rice

CEO, Co-Founder

Founding Team

Weave Bio Investors

Notable investors and investment history

Weave Bio investors
InvestorRounds
Magnetic VenturesSeries A, Pre Seed, Seed
Innovation EndeavorsSeries A, Pre Seed, Seed
Magnetic VenturesSeries A, Seed
Character CapitalSeries A
U.S. Venture PartnersSeries A
TMVSeries A
Serrado CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 4, 2026

    Messaging infrastructure processes hundreds of millions of messages.

  • Apr 4, 2026

    Platform processes billions in annual payment volume.

Weave Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Weave Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Weave Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range40
Year Founded2022
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?